Methods and compositions for modulating rad51 and homologous recombination
AssigneeThe University of Chicago
InventorsPhilip P. Connell, Douglas K. Bishop, Ralph R. Weichselbaum
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of Chicago
InventorsPhilip P. Connell, Douglas K. Bishop, Ralph R. Weichselbaum
Estimating the term…
The present invention concerns methods and compositions involving inhibitors and enhancers of RAD51, a protein involved in homologous recombination. In some embodiments, the present invention concerns methods for stimulating homologous recombination, which has a number of significant research and clinical applications. In certain other embodiments, there are methods for protecting cells using a compound that enhances RAD51 activity. Such enhancers may also be employed to prevent or reduce damage to cells that may be caused by DNA damaging agents. In other embodiments, there are methods for sensitizing cells to the effects of DNA damaging agents, which can have particular applications for cancer patients. In some embodiments of the invention, the RAD51 enhancer or inhibitor is a small molecule that directly affects RAD51 activity, such as its ability to promote filament formation.
A method for modulating a RAD51 protein in a cell comprising providing to the cell an effective amount of a RAD51 protein modulator, wherein the modulator is a small molecule that directly modulates the activity of RAD51 protein.
-7. (canceled)
-17. (canceled)
-25. (canceled)
-29. (canceled)
-60. (canceled)
A method for incorporating exogenous DNA into cells' DNA comprising:
-77. (canceled)
A method for preventing or reducing DNA damage in cells comprising providing to the cells an effective amount of a RAD51 enhancer, wherein the RAD51 enhancer directly increases RAD51 activity.
-84. (canceled)
-88. (canceled)
-104. (canceled)
Dependencies are inferred from the claim text.